Cargando…
Resistin as a Systemic Inflammation-Related Biomarker for Sarcopenia in Patients With Chronic Obstructive Pulmonary Disease
BACKGROUND: Sarcopenia is common in patients with chronic obstructive pulmonary disease (COPD) and is mainly caused by systemic inflammation. Resistin acts as a proinflammatory cytokine and is involved in the activation of multiple inflammatory signaling pathways. The aim of this study was to determ...
Autores principales: | Gao, Jinghan, Deng, Mingming, Li, Yanxia, Yin, Yan, Zhou, Xiaoming, Zhang, Qin, Hou, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315354/ https://www.ncbi.nlm.nih.gov/pubmed/35903456 http://dx.doi.org/10.3389/fnut.2022.921399 |
Ejemplares similares
-
Growth Differentiation Factor-15 as a Biomarker for Sarcopenia in Patients With Chronic Obstructive Pulmonary Disease
por: Deng, Mingming, et al.
Publicado: (2022) -
Ultrasound Assessment of the Rectus Femoris in Patients with Chronic Obstructive Pulmonary Disease Predicts Sarcopenia
por: Deng, Mingming, et al.
Publicado: (2022) -
Role of nutrition in patients with coexisting chronic obstructive pulmonary disease and sarcopenia
por: Nan, Yayun, et al.
Publicado: (2023) -
Ultrasonic Elastography of the Rectus Femoris, a Potential Tool to Predict Sarcopenia in Patients With Chronic Obstructive Pulmonary Disease
por: Deng, Mingming, et al.
Publicado: (2022) -
Clinical impacts of sarcopenic obesity on chronic obstructive pulmonary disease: a cross-sectional study
por: Wang, Zilin, et al.
Publicado: (2023)